QRxPharma Ltd (OTCQX International:QRXPY)

Data as of Oct 16
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

QRxPharma Ltd. is a commercial-stage specialty pharmaceutical company. It is focused on the development and commercialization of new treatments for pain management and central nervous system disorders. The company's product portfolio includes MoxDuo IR, MoxDuo IV and MoxDuo CR. QRxPharma was founded by Pace W. Gary and Felix de la Iglesia on Setember 19, 2002 and is headquartered in Sydney, Australia.

Contact Information

QRxPharma Ltd.
194 Miller Street
Sydney New South Wales (nsw) 2060
P:(129) 492-8021
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Edward M. RudnicChief Executive Officer
Chris J. CampbellChief Financial Officer & Secretary
Patricia T. RichardsChief Medical Officer
M. Janette DixonSenior Vice President-Global Business Development
Michael SchroederVice President-Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.